BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mosleth EF, Vedeler CA, Liland KH, McLeod A, Bringeland GH, Kroondijk L, Berven FS, Lysenko A, Rawlings CJ, Eid KE, Opsahl JA, Gjertsen BT, Myhr KM, Gavasso S. Cerebrospinal fluid proteome shows disrupted neuronal development in multiple sclerosis. Sci Rep 2021;11:4087. [PMID: 33602999 DOI: 10.1038/s41598-021-82388-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Sandi D, Kokas Z, Biernacki T, Bencsik K, Klivényi P, Vécsei L. Proteomics in Multiple Sclerosis: The Perspective of the Clinician. Int J Mol Sci 2022;23:5162. [PMID: 35563559 DOI: 10.3390/ijms23095162] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
2 Dayon L, Cominetti O, Affolter M. Proteomics of Human Biological Fluids for Biomarker Discoveries: Technical Advances and Recent Applications. Expert Rev Proteomics 2022. [PMID: 35466824 DOI: 10.1080/14789450.2022.2070477] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 He K, He S, Su M. Inter‐alpha‐trypsin inhibitor heavy chain 4: A serologic marker relating to disease risk, activity, and treatment outcomes of rheumatoid arthritis. Clinical Laboratory Analysis. [DOI: 10.1002/jcla.24231] [Reference Citation Analysis]
4 Sen MK, Almuslehi MSM, Shortland PJ, Mahns DA, Coorssen JR. Proteomics of Multiple Sclerosis: Inherent Issues in Defining the Pathoetiology and Identifying (Early) Biomarkers. Int J Mol Sci 2021;22:7377. [PMID: 34298997 DOI: 10.3390/ijms22147377] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 't Hart BA, Luchicchi A, Schenk GJ, Stys PK, Geurts JJG. Mechanistic underpinning of an inside-out concept for autoimmunity in multiple sclerosis. Ann Clin Transl Neurol 2021;8:1709-19. [PMID: 34156169 DOI: 10.1002/acn3.51401] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
6 't Hart BA, Luchicchi A, Schenk GJ, Killestein J, Geurts JJG. Multiple sclerosis and drug discovery: A work of translation. EBioMedicine 2021;68:103392. [PMID: 34044219 DOI: 10.1016/j.ebiom.2021.103392] [Reference Citation Analysis]